High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability

Journal of Physiology

Volumn 588, Issue 23, 2010, Pages 4837-4847

  Bailey, Damian M ^a   Dehnert, Christoph ^b   Luks, Andrew M ^c   Menold, Elmar ^b   Castell, Christian ^b   Schendler, Guido ^b   Faoro, Vitalie ^d   Gutowski, Mariusz ^a   Evans, Kevin A ^a   Taudorf, Sarah ^e   James, Philip E ^f   McEneny, J ^g   Young, Ian S ^g   Swenson, Erik R ^c,h   Mairbäurl, Heimo ^b   Bärtsch, Peter ^b   Berger, Marc M ^b  

^a UNIVERSITY OF GLAMORGAN   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; ASCORBIC ACID; FREE RADICAL; NITRIC OXIDE;

ADULT; ALTITUDE DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; LUNG BLOOD FLOW; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

ADULT; ALTITUDE SICKNESS; ANTIHYPERTENSIVE AGENTS; FEMALE; FREE RADICALS; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; NIFEDIPINE; NITRIC OXIDE; OXIDATIVE STRESS; OXYGEN; PULMONARY GAS EXCHANGE;

EID: 78649698425     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.194704     Document Type: Article

References (51)

1. Allemann Y, Sartori C, Lepori M, Pierre S, Melot C, Naeije R, Scherrer U & Maggiorini M (2000). Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol 279, H2013-2016.
2. Bailey D, Ainslie P, Jackson S, Richardson R & Ghatei M (2004). Evidence against redox regulation of energy homoeostasis in humans at high altitude. Clin Sci (Lond) 107, 589-600.
3. Bailey D, Raman S, McEneny J, Young I, Parham K, Hullin D, Davies B, McKeeman G, McCord J & Lewis M (2006a). Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion. Free Radic Biol Med 40, 591-600.
4. Bailey DM, Davies B & Young IS (2001). Intermittent hypoxic training: implications for lipid peroxidation induced by acute normoxic exercise in active men. Clin Sci (Lond) 101, 465-475.
5. Bailey DM, Evans KA, James PE, McEneny J, Young IS, Fall L, Gutowski M, Kewley E, McCord JM, Moller K & Ainslie PN (2009a). Altered free radical metabolism in acute mountain sickness: implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol 587, 73-85.
6. Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, Genius J, Storch-Hagenlocher B, Meisel F, McEneny J, Young IS, Steiner T, Hess K & Bartsch P (2006b). Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab 26, 99-111.
7. Bailey DM, Taudorf S, Berg RMG, Lundby C, McEneny J, Young IS, Evans KA, James PE, Shore A, Hullin DA, McCord JM, Pedersen BK & Moller K (2009b). Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness? Am J Physiol Regul Integr Comp Physiol 297, R1283-1292.
8. Bärtsch P & Gibbs JS (2007). Effect of altitude on the heart and the lungs. Circulation 116, 2191-2202.
9. Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P & Oelz O (1991). Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 325, 1284-1289.
10. Bärtsch P, Shaw S, Franciolli M, Gnadinger MP & Weidmann P (1988). Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 65, 1929-1937.
11. Berger MM, Dehnert C, Bailey DM, Luks AM, Menold E, Castell C, Schendler G, Faoro V, Mairbaurl H, Bartsch P & Swenson ER (2009). Transpulmonary plasma ET-1 and nitrite differences in high altitude pulmonary hypertension. High Alt Med Biol 10, 17-24.
12. Berger MM, Hesse C, Dehnert C, Siedler H, Kleinbongard P, Bardenheuer HJ, Kelm M, Bartsch P & Haefeli WE (2005). Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. Am J Respir Crit Care Med 172, 763-767.
13. Buettner GR (1993). The pecking order of free radicals and antioxidants: lipid peroxidation, α -tocopherol, and ascorbate. Arch Biochem Biophys 300, 535-543.
14. Buettner GR & Kiminyo KP (1992). Optimal EPR detection of weak nitroxide spin adduct and ascorbyl free radical signals. J Biochem Biophys Methods 24, 147-151.
15. Busch T, Bartsch P, Pappert D, Grunig E, Hildebrandt W, Elser H, Falke KJ & Swenson ER (2001). Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am J Respir Crit Care Med 163, 368-373.
16. Catignani GL & Bieri JG (1983). Simultaneous determination of retinol and Alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 29, 708-712.
17. Connolly MJ & Aaronson PI (2010). Cell redox state and hypoxic pulmonary vasoconstriction: Recent evidence and possible mechanisms. Respir Physiol Neurobiol (in press).
18. Corsten SA, Van Dijk B, Bakker NC, De Lange JJ & Scheffer GJ (1994). Central venous catheter placement using the ECG-guided Cavafix-Certodyn SD catheter. J Clin Anesth 6, 469-472.
19. Dehnert C, Luks AM, Schendler G, Menold E, Berger MM, Mairbaurl H, Faoro V, Bailey DM, Castell C, Hahn G, Vock P, Swenson ER & Bartsch P (2010). No evidence for interstitial lung oedema by extensive pulmonary function testing at 4, 559 m. Eur Respir J 35, 812-820.
20. Duplain H, Sartori C, Lepori M, Egli M, Allemann Y, Nicod P & Scherrer U (2000). Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med 162, 221-224.
21. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P & Scherrer U (1999). Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 99, 1713-1718.
22. Fenn WO, Rahn H & Otis AB (1946). A theoretical study of the composition of the alveolar air at altitude. Am J Physiol 146, 637-653.
23. Guzy RD & Schumacker PT (2006). Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91, 807-819.
24. Ingram TE, Pinder AG, Bailey DM, Fraser AG & James PE (2010). Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means which is not dependent upon a simultaneous elevation in plasma nitrite. Am J Physiol Heart Circ Physiol 298, H331-H339.
25. Lang CC, Karlin P, Haythe J, Tsao L & Mancini DM (2007). Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 99, 404-405.
26. Le Cras TD & McMurtry IF (2001). Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol 280, L575-582.
27. Maggiorini M, Muller A, Hofstetter D, Bartsch P & Oelz O (1998). Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med 69, 1186-1192.
28. Miserocchi G, Negrini D, Passi A & De Luca G (2001). Development of lung edema: interstitial fluid dynamics and molecular structure. News Physiol Sci 16, 66-71.
29. Nauser T & Koppenol WH (2002). The rate constant of the reaction of superoxide with nitrogen monoxide: approaching the diffusion limit. J Phys Chem A 106, 4084-4086.
30. Pacher P, Beckman JS & Liaudet L (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87, 315-424.
31. Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL & Davies KJA (2006). Free radical biology and medicine: it's a gas, man Am J Physiol Regul Integr Comp Physiol 291, R491-511.
32. Rassaf T, Feelisch M & Kelm M (2004). Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 36, 413-422.
33. Roach RC, Bartsch P, Hackett PH & Oelz O (1993). The Lake Louise acute mountain sickness scoring system. In Hypoxia and Molecular Medicine, ed. Sutton JR, Coates J & Houston CS, pp. 272-274. Queen City Printers, Burlington
34. Rogers SC, Khalatbari A, Gapper PW, Frenneaux MP & James PE (2005). Detection of human red blood cell-bound nitric oxide. J Biol Chem 280, 26720-26728.
35. Roubal WT & Tappel AL (1966). Polymerization of proteins induced by free-radical lipid peroxidation. Arch Biochem Biophys 113, 150-155.
36. Sampson JB, Cymerman A, Burse RL, Maher JT & Rock PB (1983). Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med 54, 1063-1073.
37. Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger GR, Fikrle A, Ballmer PE, Nicod P & Bartsch P (1996). Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 334, 624-629.
38. Steiner DRS, Gonzalez NC & Wood JG (2002). Interaction between reactive oxygen species and nitric oxide in the microvascular response to systemic hypoxia. J Appl Physiol 93, 1411-1418.
39. Swenson ER, Maggiorini M, Mongovin S, Gibbs JSR, Greve I, Mairbaurl H & Bartsch P (2002). Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 287, 2228-2235.
40. Thurnham DI, Smith E & Flora PS (1988). Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha- carotene, lycopene, and beta-crytoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 34, 377-381.
41. Van Faassen EE, Bahrami S, Feelisch M, Hogg N, Kelm M, Kim-Shapiro DB, Kozlov AV, Li H, Lundberg JO, Mason R, Nohl H, Rassaf T, Samouilov A, Slama-Schwok A, Shiva S, Vanin AF, Weitzberg E, Zweier J & Gladwin MT (2009). Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 29, 683-741.
42. Vock P, Fretz C, Franciolli M & Bartsch P (1989). High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology 170, 661-666.
43. Von Euler U & Liljestrand G (1946). Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12, 301-320.
44. Vuilleumier JP & Keck E (1993). Fluorimetric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J Micronutr Anal 5, 25-34.
45. Wang J, Brown MA, Tam SH, Chan MC & Whitworth JA (1997). Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol 24, 418-420.
46. Wang X & Quinn PJ (1999). Vitamin E and its function in membranes. Prog Lipid Res 38, 309-336.
47. Ward JP & McMurtry IF (2009). Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol 9, 287-296.
48. Waypa GB & Schumacker PT (2008). Oxygen sensing in hypoxic pulmonary vasoconstriction: using new tools to answer an age-old question. Exp Physiol 93, 133-138.
49. Williams NH & Yandell JK (1982). Outer-sphere electron-transfer reactions of ascorbic anions. Aust J Chem 35, 1133-1144.
50. Wolff SP (1994). Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 233, 183-189.
51. Zouaoui Boudjeltia K, Tragas G, Babar S, Moscariello A, Nuyens V, Van Antwerpen P, Gilbert O, Ducobu J, Brohee D, Vanhaeverbeek M & Van Meerhaeghe A (2009). Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients. Atherosclerosis 205, 360-362.